Stay updated on Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record presents details of the completed vactosertib and pembrolizumab study, including eligibility criteria, treatment arms, outcomes, locations, and study dates. It replaces a 403 Forbidden error page.
    Difference
    50%
    Check dated 2026-11-08T05:16:39.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T02:11:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:09:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:56:44.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:29:43.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error, indicating access to the study record is blocked. The deletions reflect removal of the previous 403 response content and navigation link from the page, pointing to an access issue rather than a study content change.
    Difference
    0.5%
    Check dated 2026-09-27T02:34:54.000Z thumbnail image

Stay in the know with updates to Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.